Damage-induced pyroptosis drives endogenous thymic regeneration via induction of Foxn1 by purinergic receptor activation
preprint
OA: closed
CC-BY-NC-ND-4.0
Abstract
ABSTRACT Endogenous thymic regeneration is a crucial process that allows for the renewal of immune competence following stress, infection or cytoreductive conditioning. Fully understanding the molecular mechanisms driving regeneration will uncover therapeutic targets to enhance regeneration. We previously demonstrated that high levels of homeostatic apoptosis suppress regeneration and that a reduction in the presence of damage-induced apoptotic thymocytes facilitates regeneration. Here we identified that cell-specific metabolic remodeling after ionizing radiation steers thymocytes towards mitochondrial-driven pyroptotic cell death. We further identified that a key damage-associated molecular pattern (DAMP), ATP, stimulates the cell surface purinergic receptor P2Y2 on cortical thymic epithelial cells (cTECs) acutely after damage, enhancing expression of Foxn1 , the critical thymic transcription factor. Targeting the P2Y2 receptor with the agonist UTPγS promotes rapid regeneration of the thymus in vivo following acute damage. Together these data demonstrate that intrinsic metabolic regulation of pyruvate processing is a critical process driving thymus repair and identifies the P2Y2 receptor as a novel molecular therapeutic target to enhance thymus regeneration. SUMMARY Thymocytes rapidly and transiently undergo pyroptosis after acute thymic damage and promote regeneration. Damage-induced redirection of pyruvate acutely enhances mitochondrial OXPHOS in thymocytes. Elevated mitochondrial ROS promotes pyroptosis in thymocytes after acute insult by driving caspase 1 cleavage. Extracellular ATP release promotes Foxn1 expression in cTECs via activation of P2Y2 Therapeutic targeting of the P2Y2 receptor promotes thymic regeneration.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (68)
- P2X Receptors: Potential Therapeutic Targets for Symptoms Associated With Lung Cancer - A Mini Review. via crossref
- doi:10.1016/j.smim.2012.04.005 via crossref
- doi:10.1007/s00281-021-00840-5 via crossref
- doi:10.1172/jci84997 via crossref
- doi:10.1126/science.1218004 via crossref
- doi:10.4049/jimmunol.0802445 via crossref
- doi:10.1002/eji.201545814 via crossref
- doi:10.1016/j.celrep.2021.109789 via crossref
- doi:10.3389/fimmu.2015.00422 via crossref
- doi:10.1681/asn.2014010117 via crossref
- doi:10.1007/s12072-018-9911-9 via crossref
- doi:10.1007/s40139-018-0162-1 via crossref
- doi:10.1038/s41419-019-1974-6 via crossref
- doi:10.1093/genetics/iyab144 via crossref
- doi:10.1023/a:1020594531159 via crossref
- doi:10.1084/jem.20061552 via crossref
- doi:10.1182/blood-2005-04-1595 via crossref
- doi:10.1242/dev.103614 via crossref
- doi:10.3389/fcell.2019.00100 via crossref
- doi:10.5483/bmbrep.2008.41.1.011 via crossref
- doi:10.1093/jmcb/mjz020 via crossref
- doi:10.3389/fphys.2020.571810 via crossref
- doi:10.3389/fphys.2019.01557 via crossref
- doi:10.1016/j.molimm.2018.09.010 via crossref
- doi:10.1016/j.biocel.2021.106013 via crossref
- doi:10.1073/pnas.1414859111 via crossref
- doi:10.1038/s41590-021-01017-w via crossref
- doi:10.1042/bj1340707 via crossref
- doi:10.7554/elife.60827 via crossref
- doi:10.1371/journal.pone.0032448 via crossref
- doi:10.1128/mcb.00153-07 via crossref
- doi:10.1038/nm1603 via crossref
- doi:10.1126/science.7535475 via crossref
- doi:10.1111/imr.12534 via crossref
- doi:10.1182/blood.2021013950 via crossref
- doi:10.1152/ajpcell.1993.265.3.c577 via crossref
- doi:10.1124/pr.58.3.3 via crossref
- doi:10.1016/j.bcp.2006.02.003 via crossref
- doi:10.3389/fphar.2018.00193 via crossref
- doi:10.1002/iub.2077 via crossref
- doi:10.3390/ijms20061446 via crossref
- doi:10.1016/s0140-6736(14)61255-1 via crossref
- doi:10.1016/j.bmcl.2016.06.048 via crossref
- doi:10.1136/annrheumdis-2011-143578 via crossref
- doi:10.2174/138161212803251853 via crossref
- doi:10.1152/ajpheart.00682.2001 via crossref
- doi:10.1152/ajpheart.2001.280.6.h2533 via crossref
- doi:10.3389/fimmu.2021.716661 via crossref
- doi:10.7554/elife.13663 via crossref
- doi:10.1007/s12031-016-0728-5 via crossref
- doi:10.18632/oncotarget.18908 via crossref
- doi:10.1074/jbc.m212754200 via crossref
- doi:10.1155/2016/2183026 via crossref
- doi:10.1038/sj.cdd.4402195 via crossref
- doi:10.1126/science.1156995 via crossref
- doi:10.1038/nri2725 via crossref
- doi:10.4049/jimmunol.1301490 via crossref
- doi:10.1371/journal.pone.0091787 via crossref
- doi:10.1371/journal.pone.0174899 via crossref
- doi:10.4049/jimmunol.1001298 via crossref
- doi:10.1016/j.lfs.2021.119850 via crossref
- doi:10.1007/s11302-011-9233-z via crossref
- doi:10.1111/j.0906-6705.2003.00110.x via crossref
- doi:10.1076/ceyr.16.10.1006.9018 via crossref
- doi:10.1152/ajpcell.00100.2009 via crossref
- doi:10.1002/cti2.1098 via crossref
- doi:10.3389/fimmu.2020.01745 via crossref
- doi:10.1084/jem.20131289 via crossref
Source provenance
- crossref
- last seen: 2026-05-23T01:00:25.018348+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-NC-ND-4.0